|
CDC’s MMWR and Medscape are proud to introduce a new FREE continuing education (CE) activity that describes changes in the proportion of unusual antibiotic resistance among selected pathogens, based on a CDC study.
 This activity is intended for infectious disease practitioners, critical care practitioners, hematologists/oncologists, internists, laboratory practitioners, pathologists, public health officials, urologists, nurses, pharmacists, and other clinicians who treat and manage patients with multidrug-resistant organism infection.
Upon completion of this activity, participants will be able to
- Describe changes from 2006 to 2015 in the annual proportion of selected pathogens that were nonsusceptible to extended-spectrum cephalosporins (ESBL phenotype) or resistant to carbapenems (carbapenem-resistant Enterobacteriaceae [CRE]), based on infection data from the National Healthcare Safety Network
- Describe findings from January to September 2017 of carbapenemase testing and screening tests, based on a Centers for Disease Control and Prevention (CDC) study
- Describe clinical implications of changes in spread of two multidrug-resistant (MDR) pathogens over time, based on a CDC study
To access this FREE MMWR / Medscape CE activity visit https://www.cdc.gov/mmwr/cme/medscape_cme.html. If you are not a registered user on Medscape, you may register for free or login without a password and get unlimited access to all continuing education activities and other Medscape features.
|
